202 / 1498
New Antibodies and Molecules
in Hodgkin Lymphoma
•
Brentuximab Vedotin (anti-CD30 ADC)
•
AFM13 (CD16/CD30 bispecific)
•
Lenalidomide (IMID)
•
Everolimus, (mTor-inhibitor)
•
Rituximab, Ofatumumab (anti-CD20)
•
Panobinostat, Mocitinostat (H-DAC inhibitors)
•
TKI´s, JAK2i, PARPi
•
PD-1 inhibitors